MedPath
FDA Approval

Desflurane

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
February 28, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Desflurane(250 mL in 250 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Piramal Critical Care Inc

805600439

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Piramal Critical Care Inc

Piramal Critical Care Inc

Piramal Critical Care Inc

805600439

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Desflurane

Product Details

NDC Product Code
66794-021
Route of Administration
RESPIRATORY (INHALATION)
Effective Date
February 28, 2023
Code: CRS35BZ94QClass: ACTIBQuantity: 250 mL in 250 mL
© Copyright 2025. All Rights Reserved by MedPath